Update on stem cell transplantation for acute leukemias

Research output: Contribution to journalArticle

Abstract

The treatment strategies for acute leukemia are undergoing very rapid change. Particularly for last 10 years, due to the rapid development of molecular targeted therapy and cell/gene therapies, the role of HSCT in the treatment scheme of acute leukemia has been changing. In the author's view, these recent changes should secure the role of HSCT in the comprehensive treatment scheme of acute leukemia. By appropriately combining the new agents with HSCT, therapy for acute leukemia is anticipated to become more effective. HSCT will provide the centerpiece for the treatment scheme, by setting up the "platform" for further interventions. Keeping these changes in mind, transplant physicians should now be exploring new areas of research such as interactions between these new agents and GVHD/GVL.

Original languageEnglish (US)
Pages (from-to)2218-2223
Number of pages6
Journal[Rinsho ketsueki] The Japanese journal of clinical hematology
Volume57
Issue number10
StatePublished - Jan 1 2016

Fingerprint

Stem Cell Transplantation
Leukemia
Molecular Targeted Therapy
Therapeutics
Cell- and Tissue-Based Therapy
Genetic Therapy
Physicians
Transplants
Research

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{a4be9e05616c46e2900fc16fbd2b01d9,
title = "Update on stem cell transplantation for acute leukemias",
abstract = "The treatment strategies for acute leukemia are undergoing very rapid change. Particularly for last 10 years, due to the rapid development of molecular targeted therapy and cell/gene therapies, the role of HSCT in the treatment scheme of acute leukemia has been changing. In the author's view, these recent changes should secure the role of HSCT in the comprehensive treatment scheme of acute leukemia. By appropriately combining the new agents with HSCT, therapy for acute leukemia is anticipated to become more effective. HSCT will provide the centerpiece for the treatment scheme, by setting up the {"}platform{"} for further interventions. Keeping these changes in mind, transplant physicians should now be exploring new areas of research such as interactions between these new agents and GVHD/GVL.",
author = "Shin Mineishi",
year = "2016",
month = "1",
day = "1",
language = "English (US)",
volume = "57",
pages = "2218--2223",
journal = "[Rinsho ketsueki] The Japanese journal of clinical hematology",
issn = "0485-1439",
publisher = "Nihon Rinsho Ketsueki Gakkai/Japan Society of Clinical Hematology",
number = "10",

}

Update on stem cell transplantation for acute leukemias. / Mineishi, Shin.

In: [Rinsho ketsueki] The Japanese journal of clinical hematology, Vol. 57, No. 10, 01.01.2016, p. 2218-2223.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Update on stem cell transplantation for acute leukemias

AU - Mineishi, Shin

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The treatment strategies for acute leukemia are undergoing very rapid change. Particularly for last 10 years, due to the rapid development of molecular targeted therapy and cell/gene therapies, the role of HSCT in the treatment scheme of acute leukemia has been changing. In the author's view, these recent changes should secure the role of HSCT in the comprehensive treatment scheme of acute leukemia. By appropriately combining the new agents with HSCT, therapy for acute leukemia is anticipated to become more effective. HSCT will provide the centerpiece for the treatment scheme, by setting up the "platform" for further interventions. Keeping these changes in mind, transplant physicians should now be exploring new areas of research such as interactions between these new agents and GVHD/GVL.

AB - The treatment strategies for acute leukemia are undergoing very rapid change. Particularly for last 10 years, due to the rapid development of molecular targeted therapy and cell/gene therapies, the role of HSCT in the treatment scheme of acute leukemia has been changing. In the author's view, these recent changes should secure the role of HSCT in the comprehensive treatment scheme of acute leukemia. By appropriately combining the new agents with HSCT, therapy for acute leukemia is anticipated to become more effective. HSCT will provide the centerpiece for the treatment scheme, by setting up the "platform" for further interventions. Keeping these changes in mind, transplant physicians should now be exploring new areas of research such as interactions between these new agents and GVHD/GVL.

UR - http://www.scopus.com/inward/record.url?scp=85011966453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011966453&partnerID=8YFLogxK

M3 - Article

C2 - 27795533

AN - SCOPUS:85011966453

VL - 57

SP - 2218

EP - 2223

JO - [Rinsho ketsueki] The Japanese journal of clinical hematology

JF - [Rinsho ketsueki] The Japanese journal of clinical hematology

SN - 0485-1439

IS - 10

ER -